Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Policy / Pricing
  • Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow
  • Policy / Pricing

Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow

BioSpace

While some large companies could start paying the full tariff in 120 days, many products, including orphan drugs, cell and gene therapies, and antibody-drug conjugates, will enjoy exemptions that waiv

Policy / PricingRead full story

pharminent April 3, 2026 (Last updated: April 3, 2026)

BioSpace

While some large companies could start paying the full tariff in 120 days, many products, including orphan drugs, cell and gene therapies, and antibody-drug conjugates, will enjoy exemptions that waiv

Policy / PricingRead full story

Post navigation

Previous: Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts
Next: US pharma tariffs of up to 100% finalised by Trump

Related Stories

  • Policy / Pricing

Mid-cap biotechs join Trump’s latest round of drug pricing deals

pharminent September 1, 2026
  • Policy / Pricing

MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones

pharminent August 27, 2026
  • Policy / Pricing

MFN affecting Swiss medicines access, says Interpharma

pharminent August 13, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.